Clinical Roundup Xcell Biosciences, AmplifyBio expand collaboration with cell and gene therapy manufacturing capabilities October 04, 2024Vol.50 No.37
Clinical Roundup First-in-human study of novel inhibitor shows promise in MTAP-deleted solid tumors October 04, 2024Vol.50 No.37
Clinical Roundup Perjeta biosimilar safe and effective for breast cancer in phase III trial October 04, 2024Vol.50 No.37
Clinical Roundup Vulnerable patients have a decreased mortality risk when treated at CoC-accredited hospitals, ACS study says September 27, 2024Vol.50 No.36
Clinical Roundup UCLA investigators develop collection of sarcoma patient-derived organoids for personalized cancer treatments September 27, 2024Vol.50 No.36
Clinical Roundup Imfinzi + chemo shows improved EFS and OS in muscle-invasive bladder cancer September 20, 2024Vol.50 No.35
Clinical Roundup Follow-up data for Imfinzi + Imjudo shows OS benefit in unresectable HCC September 20, 2024Vol.50 No.35
Clinical Roundup Adjuvant Keytruda prolongs DFS in high-risk bladder cancer September 20, 2024Vol.50 No.35
Clinical Roundup Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma September 20, 2024Vol.50 No.35
